Edap Tms (NASDAQ:EDAP) Share Price Passes Above 200 Day Moving Average – Here’s Why

Edap Tms S.A. (NASDAQ:EDAP) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.79 and traded as high as $4.72. Edap Tms shares last traded at $4.52, with a volume of 31,354 shares changing hands.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Wall Street Zen upgraded shares of Edap Tms to a “hold” rating in a research report on Saturday, February 7th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Edap Tms in a report on Monday, December 29th. Finally, Jefferies Financial Group reiterated a “hold” rating and issued a $2.00 target price on shares of Edap Tms in a research note on Thursday, November 6th. One equities research analyst has rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $8.50.

Edap Tms Trading Down 4.0%

The company has a current ratio of 1.41, a quick ratio of 0.97 and a debt-to-equity ratio of 0.04. The stock has a market cap of $169.00 million, a P/E ratio of -7.93 and a beta of -0.16. The business’s fifty day simple moving average is $3.90 and its 200 day simple moving average is $2.79.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Sage Mountain Advisors LLC acquired a new stake in shares of Edap Tms in the 2nd quarter valued at $165,000. Rock Springs Capital Management LP lifted its stake in shares of Edap Tms by 1.3% during the fourth quarter. Rock Springs Capital Management LP now owns 1,286,500 shares of the medical equipment provider’s stock valued at $4,233,000 after acquiring an additional 16,500 shares during the period. Kovack Advisors Inc. bought a new position in Edap Tms in the fourth quarter valued at about $53,000. Leonteq Securities AG acquired a new stake in Edap Tms in the fourth quarter worth about $313,000. Finally, Financial Planning Navigators CORP acquired a new stake in Edap Tms in the fourth quarter worth about $33,000. Institutional investors and hedge funds own 62.74% of the company’s stock.

About Edap Tms

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States.